Skip to main content
Home
  • About
    • About the Navigator
    • Navigator FAQs
  • Guides
    • For Patients and Caregivers
    • For Physicians and Healthcare Providers
    • For Companies and Sponsors
  • Company Directory
    • View Company Directory
    • Submit Company Information
  • Resources
  • Expanded Access eRequest
  • facebook
  • twitter
  • linkedin
  • youtube
Home
  • About
    • About the Navigator
    • Navigator FAQs
  • Guides
    • For Patients and Caregivers
    • For Physicians and Healthcare Providers
    • For Companies and Sponsors
  • Company Directory
    • View Company Directory
    • Submit Company Information
  • Resources
  • Expanded Access eRequest

NIV and CPAP Failure Predictors in COVID-19 Associated Respiratory Failure

  • Read more about NIV and CPAP Failure Predictors in COVID-19 Associated Respiratory Failure

A Clinical Trial of Gargling Agents in Reducing Intraoral Viral Load Among COVID-19 Patients

  • Read more about A Clinical Trial of Gargling Agents in Reducing Intraoral Viral Load Among COVID-19 Patients

Assessment of Serological Techniques for Screening Patients Regarding COVID-19-COVID-SER

  • Read more about Assessment of Serological Techniques for Screening Patients Regarding COVID-19-COVID-SER

French COVID Cohort

  • Read more about French COVID Cohort

Isatuximab in Combination With Lenalidomide and Dexamethasone in High-risk Smoldering Multiple Myeloma

  • Read more about Isatuximab in Combination With Lenalidomide and Dexamethasone in High-risk Smoldering Multiple Myeloma

Immunity and Safety of Covid-19 Synthetic Minigene Vaccine

  • Read more about Immunity and Safety of Covid-19 Synthetic Minigene Vaccine

Eculizumab (Soliris) in Covid-19 Infected Patients

  • Read more about Eculizumab (Soliris) in Covid-19 Infected Patients

Safety and Immunity of Covid-19 aAPC Vaccine

  • Read more about Safety and Immunity of Covid-19 aAPC Vaccine

Bevacizumab in Patients With Severe Covid-19

  • Read more about Bevacizumab in Patients With Severe Covid-19

Nitric Oxide Gas Inhalation Therapy for Mild/Moderate COVID-19

  • Read more about Nitric Oxide Gas Inhalation Therapy for Mild/Moderate COVID-19

Pagination

  • First page « First
  • Previous page ‹ Previous
  • …
  • Page 223
  • Page 224
  • Page 225
  • Page 226
  • Current page 227
  • Page 228
  • Page 229
  • Page 230
  • Page 231
  • …
  • Next page Next ›
  • Last page Last »
Subscribe to

Subscribe for updates from the Reagan-Udall Foundation for the FDA

Subscribe
(202) 849 - 2075
1333 New Hampshire Ave, NW
Suite 420
Washington, DC 20036
navigator@reaganudall.org
  • facebook
  • twitter
  • linkedin
  • youtube

© Reagan-Udall Foundation for the FDA
© Reagan-Udall Foundation for the FDA